Drugs / Tetanus toxoid vaccine
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01644968 | Nov 2003 → May 2009 | cancer of unknown primary site | Providence Health & Services | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT02700841 | Jan 2020 → Dec 2022 | plasma cell myeloma | University of Nebraska | Terminated | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT01559597 | Nov 2012 → Mar 2013 | tetanus | Epicentre | Completed | No outcome recorded |
| — | NCT00001119 | Oct 1999 → Jun 2004 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Also used as a comparator or background therapy in 5 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT02109354 Comparator | Jun 2013 → Feb 2015 | HIV infectious disease | HIV Vaccine Trials Network | Completed | No outcome recorded |
| Phase 1 | NCT00279734 Background | Aug 2004 → Jan 2005 | rheumatoid arthritis | Bristol-Myers Squibb | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00008866 Background | — | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Withdrawn | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01199861 Background | Aug 2010 → May 2011 | multiple sclerosis | Novartis | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00000943 Background | ? → Nov 2005 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tetanus Toxoid Vaccine | “Tetanus toxoid vaccine 0.5ml (5 LF/ml tetanus toxoid)on Day 29” NCT01644968 ↗8“the intramuscular tetanus toxoid vaccine” PMID 17425783 ↗ 2007 |
| Modality | Vaccine | “Tetanus Toxoid Vaccine” NCT00000943 ↗ |
| Route | Intramuscular | “intramuscular vaccination with tetanus toxoid” NCT00001119 ↗ |